LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data.
Objectives: This study aimed to quantitatively compare the efficacy and safety of long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) and LABA/inhaled corticosteroid (ICS) fixed-dose combinations (FDCs) in preventing moderate or severe chronic obstructive pulmonary disease (COPD)...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 79; no. 10; pp. 1321 - 1333 |
|---|---|
| Autores principales: | , , , , |
| Formato: | equations & formulas research systematic review tables/charts Journal Article |
| Publicado: |
Springer Nature
Oct2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |